SEARCH

SEARCH BY CITATION

References

  • 1
    Colletti LM, Burtch GD, Remick DG, Kunkel SL, Stricter RM, Guice KS, Oldham KT, et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 1990; 49: 268272.
  • 2
    Colletti LM, Remick DG, Burtch GD, Kunkel SL, Stricter RM, Campbell DA Jr. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 19361943.
  • 3
    McCurry KR, Campbell DA Jr, Scales WE, Warren JS, Remick DG. Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J Surg Res 1993; 55: 4954.
  • 4
    Suzuki S, Toledo-Pereyra LH, Rodriguez F, Lopez F. Role of Kupffer cells in neutrophil activation and infiltration following total hepatic ischemia and reperfusion. Circ Shock 1994; 42: 204209.
  • 5
    Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 33553359.
  • 6
    Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation 1993; 55: 12651272.
  • 7
    Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J Exp Med 1989; 170: 16271633.
  • 8
    Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, Waltersdorph AM. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986; 136: 42204225.
  • 9
    Schmeling DJ, Caty MG, Oldham KT, Guice KS, Hinshaw DB. Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion. Surgery 1989; 106: 195202.
  • 10
    Klausner JM, Anner H, Paterson IS, Kobzic L, Valeri CR, Shepro D, Hechtman HB. Lower torso ischemia-induced lung injury is leukocyte dependent. Ann Surg 1988; 208: 761767.
  • 11
    Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 10451049.
  • 12
    Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEES Lett 1992; 307: 97101.
  • 13
    Sekido K, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993; 365: 654657.
  • 14
    Watanabe K, Kinoshita S, Nakagawa H. Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelioid cell line of normal rat kidney (NRK-52E cell). Biochem Biophys Res Commun 1989; 161: 10931099.
  • 15
    Watanabe K, Konishi K, Fujioka M, Kinoshita S, Nakagawa H. The neutrophil chemoattractant produced by the rat kidney epithelioid cell line NRK-52E is a protein related to the KC/gro protein. J Biol Chem 1989; 264: 1955919563.
  • 16
    Watanabe K, Koizumi F, Kurashige Y, Tsurufuji S, Nakagawa H. Rat CINC, a member of the interleukin-8 family, is a neutrophispecific chemoattractant in vivo. Exp Mol Pathol 1991; 55: 3037.
  • 17
    Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987; 39: 97145.
  • 18
    Read RA, Moore EE, Moore FA, Carl VS, Banerjee A. Plateletactivating factor—induced polymorphonuclear neutrophil priming independent of CD11B adhesion. Surgery 1993; 114: 308313.
  • 19
    Dubois C, Bissonnette E, Rola-Pleszczynski M. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. J Immunol 1989; 143: 964970.
  • 20
    Ruis NM, Rose JK, Valone FH. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor. Lipids 1991; 26: 10601064.
  • 21
    Kuipers B, Van der Poll T, Levi M, Van Deventer SJH, Ten Gate H, Imai Y, Hack CE, et al. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees. J Immunol 1994; 152: 24382446.
  • 22
    Nishiyama R, Nakamura S, Suzuki S, Baba S. Platelet-activating factor in hepatic ischemia/reperfusion injury. Transplantation 1993; 55: 12611265.
  • 23
    Ontell SJ, Makowka L, Trager J, Mazzaferro V, Ove P, Starzl TE. Pharmacologic modulation of experimental postischemic hepatic function. Ann Surg 1989; 209: 200210.
  • 24
    Zhou W, McCollum MO, Levine BA, Olson MS. Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology 1992; 16: 12361240.
  • 25
    Wang K, Monden M, Kanai T, Gotoh M, Umeshita K, Ukei T, Mori T. Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats. Surgery 1993; 113: 7683.
  • 26
    Takatani M, Maezaki N, Imura Y, Terashita Z, Nishikawa K, Tsushima S. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309. Adv Prostaglandin Thromboxane Leukot Res 1990; 21: 943946.
  • 27
    Terashita Z, Kawamura M, Takatani M, Tsushima S, Imura Y, Nishikawa K. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J Pharmacol Exp Ther 1992; 260: 748755.
  • 28
    Suzuki S, Nakamura S, Koizumi T, Sakaguti S, Baba S, Muro H, Fujise Y. The beneficial effect of a prostaglandin 12 analog on ischemic rat liver. Transplantation 1991; 52: 978983.
  • 29
    Pizarro TT, Malinowska K, Kovacs EJ, Clancy J Jr, Robinson JA, Piccinini LA. Induction of TNFα and TNF β gene expression in rat cardiac transplants during allograft rejection. Transplantation 1933; 56: 399404.
  • 30
    Lida M, Watanabe K, Tsurufuji M, Takaishi K, Lizuka Y, Tsurufuji S. Level of neutrophil chemotactic factor CINC/gro, a member of the interleukin-8 family, associated with lipopolysaccharide-induced inflammation in rats. Infect Immun 1992; 60: 12681272.
  • 31
    Uehara K, Hori K, Nakano M, Koga S. High sensitive chemiluminescence method for determining myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1991; 199: 191196.
  • 32
    Nishida A, Kimura H, Nakano M, Goto T. A sensitive and specific chemiluminescence method for estimating the ability of human granulocytes and monocytes to generate O2. Clin Chim Acta 1989; 179: 177182.
  • 33
    Koga S, Nakano M, Uehara K. Mechanism for the generation of superoxide anion and singlet oxygen during heme compoundcatalyzed linoleic acid hydroperoxide decomposition. Arch Biochem Biophys 1991; 289: 223229.
  • 34
    Schlayer HJ, Laaff H, Peters T, Woort-Menker M, Estler HC, Karck U, Schaefer HE, et al. Involvement of tumor necrosis factor in endotoxin-triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol 1988; 7: 239249.
  • 35
    McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159163.
  • 36
    Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988; 255: H1269H1275.
  • 37
    Lewis MS, Whatley RE, Cain P, McLntyre TM, Prescott SM, Zimmerman GA. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial celldependent neutrophil adhesion. J Clin Invest 1988; 82: 20452055.
  • 38
    Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990; 192: 245261.
  • 39
    Berkow RJ, Wang D, Larrick JW, Dodson RW, Howard TH. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol 1987; 139: 37833791.
  • 40
    Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 1991; 212: 694700.
  • 41
    Camussi G, Bussolino F, Salvidio G, Baglioni C. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonu-clear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 1987; 166: 13901404.
  • 42
    Rabinovici R, Yue T, Farhat M, Smith EF, Esser KM, Slivjak M, Feuerstein G. Platelet activating factor (PAF) and tumor necrosis factor-α (TNFα) interactions in endotoxemic shock: Studies with BN 50739, a novel PAF antagonist. J Pharmacol Exp Ther 1990; 255: 256263.
  • 43
    Chao W, Liu H, BeBuysere M, Hanahan DJ, Olson MS. Identification of receptors for platelet-activating factor in rat Kupffer cells. J Biol Chem 1989; 264: 1359113598.
  • 44
    Hechtman DH, Cybulsky MI, Fuchs HJ, Baker JB, Gimbrone MA Jr. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 1991; 147: 883892.
  • 45
    Ormrod DJ, Harrison GL, Miller TE. Inhibition of neutrophil myeloperoxidase activity by selected tissues. J Pharmacol Methods 1987; 18: 137142.
  • 46
    Spitzer JA, Zhang P, Mayer AMS. Functional characterization of peripheral circulating and liver recruited neutrophils in endotoxic rats. J Leukoc Biol 1994; 56: 166173.